Session Details
[3-SS2]Translational Research Program (Program for supporting academia-launched medical startups
Wed. Mar 18, 2026 8:30 AM - 10:00 AM JST
Wed. Mar 18, 2026 11:30 PM - 1:00 AM UTC
Wed. Mar 18, 2026 11:30 PM - 1:00 AM UTC
Room 2(A200)
Chair:Hitoshi Kuboniwa(Renzoku Biologics Co., Ltd), Makoto Shimasaki(Ehrlich Partners Inc.)
[3-SS2-01]My thoughts on this project as a program supervisor (PS)
*Hitoshi Kuboniwa1 (1. Renzoku Biologics Co., Ltd)
[3-SS2-02]Introduction of the AMED “Program for Supporting Academia-Launched Medical Startups” and Initiatives in AMED Phase III
*Yoshikatsu Koga1 (1. Japan Agency for Medical Research and Development)
[3-SS2-03]Development of Therapeutics Targeting Synapses for Chronic Itching and Chronic Pain
*So Takasugi1 (1. Keio University)
[3-SS2-04]Polyphenol-Introduced Polymer/Metal Ion Complex for Intracellular Antibody Therapeutics
*Yuto Honda1 (1. Institute of Science Tokyo, Institute of Innovative Research)
